| __timestamp | Geron Corporation | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 16758000 | 44820000 |
| Thursday, January 1, 2015 | 17793000 | 82080000 |
| Friday, January 1, 2016 | 18761000 | 97130000 |
| Sunday, January 1, 2017 | 19287000 | 121271000 |
| Monday, January 1, 2018 | 18707000 | 153548000 |
| Tuesday, January 1, 2019 | 20893000 | 202541000 |
| Wednesday, January 1, 2020 | 25678000 | 245164000 |
| Friday, January 1, 2021 | 29665000 | 285773000 |
| Saturday, January 1, 2022 | 43628000 | 325998000 |
| Sunday, January 1, 2023 | 69135000 | 332540000 |
Unleashing the power of data
In the competitive world of biotechnology, managing operational costs is crucial for success. This analysis compares the Selling, General, and Administrative (SG&A) expenses of PTC Therapeutics, Inc. and Geron Corporation from 2014 to 2023. Over this period, PTC Therapeutics consistently outpaced Geron Corporation in SG&A spending, reflecting its aggressive growth strategy. By 2023, PTC's SG&A expenses surged by approximately 640% from 2014, reaching over $332 million, while Geron's expenses increased by around 312%, peaking at nearly $69 million. This disparity highlights PTC's expansive operational scale compared to Geron. The data suggests that PTC's higher investment in administrative and sales functions may be driving its market presence, whereas Geron maintains a more conservative approach. Understanding these trends provides valuable insights into each company's strategic priorities and market positioning.
Bristol-Myers Squibb Company vs PTC Therapeutics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Genmab A/S and PTC Therapeutics, Inc.
Comparing SG&A Expenses: Incyte Corporation vs PTC Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of Grifols, S.A. and PTC Therapeutics, Inc.
Selling, General, and Administrative Costs: Cytokinetics, Incorporated vs PTC Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of Opthea Limited and PTC Therapeutics, Inc.
PTC Therapeutics, Inc. vs Perrigo Company plc: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of PTC Therapeutics, Inc. and Bausch Health Companies Inc.
Who Optimizes SG&A Costs Better? PTC Therapeutics, Inc. or MannKind Corporation
Who Optimizes SG&A Costs Better? Vericel Corporation or Geron Corporation
Cost Management Insights: SG&A Expenses for HUTCHMED (China) Limited and Geron Corporation
Cost Management Insights: SG&A Expenses for Protagonist Therapeutics, Inc. and Geron Corporation